Valproate-induced worsening of seizures: Clue to underlying diagnosis

Journal of Child Neurology

Volumn 26, Issue 10, 2011, Pages 1319-1321

  Dhamija, Radhika ^a   Gavrilova, Ralitza H ^a   Wirrell, Elaine C ^a  

^a MAYO CLINIC   (United States)

Author keywords

glycine; hepatotoxicity; nonketotic hyperglycinemia; seizures; valproate sodium

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ARTICLE; CASE REPORT; CHILD; DEVELOPMENTAL DISORDER; FAILURE TO THRIVE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HUMAN; HYPERGLYCINEMIA; MEDICAL HISTORY; MUSCLE HYPOTONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE;

ANTICONVULSANTS; CHILD, PRESCHOOL; FEMALE; HUMANS; SEIZURES; VALPROIC ACID;

EID: 80054035533     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811402204     Document Type: Article

References (15)

1. Kerwin RW, Taberner PV. The mechanism of action of sodium valproate. Gen Pharmacol. 1981 ; 12 (2). 71-75 (Pubitemid 11166981)
2. Polc P. Enhancement of GABAergic inhibition: a mechanism of action of benzodiazepines, phenobarbital, valproate and L-cycloserine in the cat spinal cord. Electroencephalogr Clin Neurophysiol Suppl. 1982 ; 36: 188-198
3. Carr RB, Shrewsbury K. Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry. 2007 ; 164 (7). 1020-1027 (Pubitemid 47121390)
4. Horiuchi M, Imamura Y, Nakamura N, Maruyama I, Saheki T. Carbamoylphosphate synthetase deficiency in an adult: deterioration due to administration of valproic acid. J Inherit Metab Dis. 1993 ; 16 (1). 39-45 (Pubitemid 23114294)
5. Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol. (Phila). Feb 2009 ; 47 (2). 101-111
6. Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity-what is the evidence?. Crit Care. 2005 ; 9 (5). 431-440 (Pubitemid 41498538)
7. Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid overdose: a systematic review of published cases. Ann Pharmacother. 2010 ; 44 (7-8). 1287-1293
8. Demirel N, Bas AY, Zenciroglu A, Aydemir C, Kalkanoglu S, Coskun T. Neonatal non-ketotic hyperglycinemia: report of five cases. Pediatr Int. 2008 ; 50 (1). 121-123 (Pubitemid 351239393)
9. Hall DA, Ringel SP. Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy. Mov Disord. 2004 ; 19 (4). 485-486 (Pubitemid 38559657)
10. Kikuchi G, Motokawa Y, Yoshida T, Hiraga K. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci. 2008 ; 84 (7). 246-263
11. Steiner RD, Sweetser DA, Rohrbaugh JR, Dowton SB, Toone JR, Applegarth DA. Nonketotic hyperglycinemia: atypical clinical and biochemical manifestations. J Pediatr. 1996 ; 128 (2). 243-246 (Pubitemid 26065951)
12. Wiltshire EJ, Poplawski NK, Harrison JR, Fletcher JM. Treatment of late-onset nonketotic hyperglycinaemia: effectiveness of imipramine and benzoate. J Inherit Metab Dis. 2000 ; 23 (1). 15-21 (Pubitemid 30071957)
13. Kochi H, Hayasaka K, Hiraga K, Kikuchi G. Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Arch Biochem Biophys. 1979 ; 198 (2). 589-597 (Pubitemid 10141052)
14. Morrison PF, Sankar R, Shields WD. Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia. Pediatr Neurol. 2006 ; 35 (5). 356-358 (Pubitemid 44636130)
15. Van Hove JL, Vande Kerckhove K, Hennermann JB, et al. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis. 2005 ; 28 (5). 651-663 (Pubitemid 41349251)